Buddy Creech Archive — Page 1 of 4

C. difficile bacteria (image courtesy of CDC/Jennifer Oosthuizen)
August 11, 2026

Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older

“C. diff is one of those infections that turns a routine hospital stay or a course of antibiotics into something far more serious, and older adults bear the brunt of it.”

Atomic model of a chikungunya virus particle, shown as a spherical molecular surface with densely packed red, yellow, and gray structures.
December 11, 2024

Vanderbilt joins national effort to develop alphavirus vaccines

The project aims to design computational “tool kits” that can speed development of multi-virus vaccines targeting some of the greatest infectious threats to human health.

3D rendering of an enterovirus D68 particle covered by red, yellow, and blue viral proteins and orange and purple antibodies, overlaid on a colorized electron micrograph showing green virus particles.
June 28, 2024

Antibody trial launched to address enterovirus threat

Enterovirus D68 has caused an increasing number of infections during the past decade and is associated with acute flaccid myelitis, a polio-like condition that mostly affects children and causes sudden weakness and paralysis.

Silhouettes of migrating Canada geese flying across a sunset sky above a dark tree-lined horizon.
January 17, 2024

Bird flu vaccine more effective with potent adjuvant

The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases.

Three panelists sit onstage during an Annual Spring Donor Celebration, with a patterned backdrop and podium visible.
May 24, 2023

Spring event honors donors’ support and generosity

Members of Vanderbilt University Medical Center’s Canby Robinson Society recently joined CEO and President Jeff Balser, MD, PhD, and his wife, Melinda, at Cheekwood Botanic Hall for the Spring Donor Celebration, an annual event honoring donors for their loyal support.

Three-dimensional illustration of a coronavirus particle with a textured gray spherical surface, red spike proteins, and smaller yellow surface structures; blurred particles appear in the background.
November 4, 2022

Study finds Moderna’s COVID-19 vaccine safe and effective for young children

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.